Arnhold J, Malle E
Antioxidants (Basel). 2022; 11(5).
PMID: 35624754
PMC: 9138014.
DOI: 10.3390/antiox11050890.
Hayes E, Murphy M, Pohl K, Browne N, McQuillan K, Saw L
Front Immunol. 2021; 11:600033.
PMID: 33391268
PMC: 7775508.
DOI: 10.3389/fimmu.2020.600033.
Vlasova I
Molecules. 2018; 23(10).
PMID: 30297621
PMC: 6222727.
DOI: 10.3390/molecules23102561.
Koyani C, Flemmig J, Malle E, Arnhold J
Arch Biochem Biophys. 2015; 571:1-9.
PMID: 25731855
PMC: 4388333.
DOI: 10.1016/j.abb.2015.02.028.
Puntoni M, Sbrana F, Bigazzi F, Minichilli F, Ferdeghini E, Sampietro T
Lipids Health Dis. 2011; 10:185.
PMID: 22014237
PMC: 3213072.
DOI: 10.1186/1476-511X-10-185.
Structural evidence of substrate specificity in mammalian peroxidases: structure of the thiocyanate complex with lactoperoxidase and its interactions at 2.4 A resolution.
Sheikh I, Singh A, Singh N, Sinha M, Baskar Singh S, Bhushan A
J Biol Chem. 2009; 284(22):14849-56.
PMID: 19339248
PMC: 2685666.
DOI: 10.1074/jbc.M807644200.
NADPH as a co-substrate for studies of the chlorinating activity of myeloperoxidase.
Auchere F
Biochem J. 1999; 343 Pt 3:603-13.
PMID: 10527939
PMC: 1220592.
Sulphoxidation reaction catalysed by myeloperoxidase from human leucocytes.
Martin C, Gaggero N, Pasta P, Carrea G, Colonna S
Biochem J. 1998; 335 ( Pt 1):27-33.
PMID: 9742209
PMC: 1219748.
DOI: 10.1042/bj3350027.
Lipid deterioration: beta-carotene destruction and oxygen evolution in a system containing lactoperoxidase, hydrogen peroxide and halides.
Kanner J, Kinsella J
Lipids. 1983; 18(3):198-203.
PMID: 6855479
DOI: 10.1007/BF02534548.
Mechanisms of tumour cell destruction by PMA-activated human neutrophils.
Dallegri F, Frumento G, Patrone F
Immunology. 1983; 48(2):273-9.
PMID: 6295926
PMC: 1453919.
Monocyte and granulocyte-mediated tumor cell destruction. A role for the hydrogen peroxide-myeloperoxidase-chloride system.
Weiss S, Slivka A
J Clin Invest. 1982; 69(2):255-62.
PMID: 6276438
PMC: 370973.
DOI: 10.1172/jci110447.
Role of hydrogen peroxide in neutrophil-mediated destruction of cultured endothelial cells.
Weiss S, Young J, LoBuglio A, Slivka A, Nimeh N
J Clin Invest. 1981; 68(3):714-21.
PMID: 6268662
PMC: 370853.
DOI: 10.1172/jci110307.
Some enzymatic characteristics of eosinophil peroxidase from patients with eosinophilia and from healthy donors.
Bos A, Wever R, Hamers M, Roos D
Infect Immun. 1981; 32(2):427-31.
PMID: 6265355
PMC: 351460.
DOI: 10.1128/iai.32.2.427-431.1981.
Heme-linked ionizations of myeloperoxidase detected by Raman difference spectroscopy. A comparison with plant and yeast peroxidases.
Stump R, DEANIN G, Oliver J, Shelnutt J
Biophys J. 1987; 51(4):605-10.
PMID: 3034344
PMC: 1329932.
DOI: 10.1016/S0006-3495(87)83385-4.
Killing of Actinobacillus actinomycetemcomitans by the human neutrophil myeloperoxidase-hydrogen peroxide-chloride system.
Miyasaki K, Wilson M, Genco R
Infect Immun. 1986; 53(1):161-5.
PMID: 3013779
PMC: 260091.
DOI: 10.1128/iai.53.1.161-165.1986.
Influence of superoxide on myeloperoxidase kinetics measured with a hydrogen peroxide electrode.
Kettle A, Winterbourn C
Biochem J. 1989; 263(3):823-8.
PMID: 2557013
PMC: 1133504.
DOI: 10.1042/bj2630823.
Myeloperoxidase, hydrogen peroxide, chloride antimicrobial system: nitrogen-chlorine derivatives of bacterial components in bactericidal action against Escherichia coli.
Thomas E
Infect Immun. 1979; 23(2):522-31.
PMID: 217834
PMC: 414195.
DOI: 10.1128/iai.23.2.522-531.1979.
Myeloperoxidase-Cl--H2O2 bactericidal system: effect of bacterial membrane structure and growth conditions.
Rest R, Spitznagel J
Infect Immun. 1978; 19(3):1110-2.
PMID: 205505
PMC: 422307.
DOI: 10.1128/iai.19.3.1110-1112.1978.
Myeloperoxidase-hydrogen peroxide-chloride antimicrobial system: effect of exogenous amines on antibacterial action against Escherichia coli.
Thomas E
Infect Immun. 1979; 25(1):110-6.
PMID: 39030
PMC: 414428.
DOI: 10.1128/iai.25.1.110-116.1979.
